Detection of sars-cov-2 variant
AssigneeBoard of Regents, The University of Texas System
InventorJeffrey A. SORELLE
Life of this patent
Estimating the term…
Abstract
Provided herein are compositions and methods for detecting novel SARS-COV-2 variants. Disclosed herein are nucleic acid constructs that can be used as primers in various molecular assays to identify and distinguish new variants of the SARS-COV-2 virus. Also provided are methods of using said nucleic acid constructs to identify and distinguish new variants of the SARS-COV-2 virus.
Claims24
A composition for amplifying a SARS-COV-2 nucleic acid, the composition comprising at least one set of nucleic acid primers (primer set) selected from:
- (i) a first primer set comprising a first nucleic acid at least 15 nucleotides in length and having at least 85% sequence identity to SEQ ID NO:
- 1, and a second nucleic acid at least 15 nucleotides in length and having at least 85% sequence identity to SEQ ID NO:
- 2,
- (ii) a second primer set comprising a first nucleic acid at least 15 nucleotides in length and having at least 85% sequence identity to SEQ ID NO:
- 14, and a second nucleic acid at least 15 nucleotides in length and having at least 85% sequence identity to SEQ ID NO:15,
- (iii) a third primer set comprising a first nucleic acid at least 15 nucleotides in length and having at least 85% sequence identity to SEQ ID NO:
- 20, and a second nucleic acid at least 15 nucleotides in length and having at least 85% sequence identity to SEQ ID NO:
- 21,
- (iv) a fourth primer set comprising a first nucleic acid at least 15 nucleotides in length and having at least 85% sequence identity to SEQ ID NO:
- 16, and a second nucleic acid at least 15 nucleotides in length and having at least 85% sequence identity to SEQ ID NO:
- 17,
- (v) a fifth primer set comprising a first nucleic acid at least 15 nucleotides in length and having at least 85% sequence identity to SEQ ID NO:
- 22, and a second nucleic acid at least 15 nucleotides in length and having at least 85% sequence identity to SEQ ID NO:
- 23,
- (vi) a sixth primer set comprising a first nucleic acid at least 15 nucleotides in length and having at least 85% sequence identity to SEQ ID NO:
- 9, a second nucleic acid at least 15 nucleotides in length and having 85% sequence identity to SEQ ID NO:
- 10, and a third nucleic acid consisting of up to 15 nucleotides and having at least 85% sequence identity to SEQ ID NO:
- 11,
- (vii) a seventh primer set comprising a first nucleic acid at least 15 nucleotides in length and having at least 85% sequence identity to SEQ ID NO:
- 9, a second nucleic acid at least 15 nucleotides in length and having 85% sequence identity to SEQ ID NO:
- 12, and a third nucleic acid at least 15 nucleotides in length and having 85% sequence identity to SEQ ID NO:
- 13, and
- (viii) an eighth primer set comprising a first nucleic acid at least 15 nucleotides in length and having at least 85% sequence identity to SEQ ID NO:
- 9, a second nucleic acid at least 15 nucleotides in length and having at least 85% sequence identity to SEQ ID NO:
- 18, and a third nucleic acid at least 15 nucleotides in length and having 85% sequence identity to SEQ ID NO:
- 19.
2-6. (canceled)
A method for detecting a SARS-COV-2 variant, the method comprising:
- (a) amplifying a nucleic acid in a sample suspected of comprising the SARS-COV-2 variant, the variant comprising at least one insertion, deletion or single nucleotide polymorphism (SNP) as compared to a wildtype SARS-COV-2 nucleic acid, and (b) detecting an amplicon produced in (a);
- wherein amplifying the nucleic acid comprises:
- (i) performing a polymerase chain reaction using at least one set of nucleic acids (primer set), wherein the primer set amplifies a nucleic acid of the SARS-COV-2 variant comprising the insertion or deletion and the amplicon detected in (b) is larger or smaller than a corresponding amplicon generated from a wildtype SARS-COV-2 nucleic acid;
- and/or
- (ii) performing a polymerase chain reaction using a first nucleic acid primer, a second nucleic acid primer and third nucleic acid primer, wherein the first nucleic acid primer preferentially anneals to a nucleic acid comprising a mutant allele of the SNP, the second nucleic acid primer preferentially anneals to a nucleic acid comprising wildtype allele of the SNP, and the third nucleic acid allows for the amplification of a nucleic acid comprising the SNP.
-18. (canceled)
21-22. (canceled)
27-33. (canceled)
A method of generating a primer for detecting a single nucleotide polymorphism (SNP) in a nucleic acid, the method comprising:
- (a) providing a first nucleic acid sequence complementary to a nucleic acid comprising a mutant allele of the SNP, wherein the first nucleic acid sequence comprises a terminal 3′ nucleotide complementary to either the mutant or the wildtype nucleotide at the location of the SNP;
- (b) substituting an adenine (A) for a thymine (T) (T>A substitution) one base pair upstream (5′ direction) of the terminal 3′ nucleotide complementary to the mutant or wildtype nucleotide at the location of the SNP to generate a mutant primer sequence or a wildtype primer sequence;
- and
- (c) generating a mutant primer comprising the mutant primer sequence and/or a wildtype primer comprising the wildtype primer sequence;
- wherein binding of the mutant primer to a wildtype allele or the binding of the wildtype primer to a mutant allele is destabilized as compared to a mutant primer or wildtype primer without the T>A substitution.
A method of generating a primer for detecting a single nucleotide polymorphism (SNP) in a nucleic acid, the method comprising:
- (a) providing a first nucleic acid sequence complementary to a nucleic acid comprising a mutant allele of the SNP, wherein the first nucleic acid sequence comprises a terminal 3′ nucleotide complementary to the mutant nucleotide at the location of the SNP;
- (b) generating a mutant primer sequence by substituting an adenine (A) for a cytosine (C) (C>A substitution) two base pairs upstream (5′ direction) of the terminal 3′ nucleotide that is complementary to the mutant allele;
- and
- (c) preparing an isolated nucleic acid primer (mutant primer) comprising the mutant primer sequence, wherein the mutant primer binds the mutant allele with a higher specificity than an equivalent primer without the C>A substitution.
An isolated nucleic acid primer comprising a nucleotide sequence consisting of any one of SEQ ID NOs:
- 1 to 50.
42-46. (canceled)
Dependencies are inferred from the claim text.